Access Statistics for Jo Seldeslachts

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Retrospective Evaluation of the GDF/Suez Merger: Effects on Gas Hub Prices 0 0 0 46 1 3 6 85
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 1 21 5 6 7 42
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 23 4 6 9 49
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 22 6 8 14 51
A retrospective evaluation of the GDF/Suez merger: Effects on gas hub prices 0 0 0 55 2 6 8 71
Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development 1 2 3 13 8 13 21 33
Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development 0 0 2 16 6 9 13 25
Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development 1 1 2 2 3 6 11 13
Are M&As Spurring or Stifling Innovation? Evidence from Antidiabetic Drug Development 0 1 27 27 10 15 51 51
Are M&As spurring or stifling innovation? Evidence from antidiabetic drug development 0 0 12 12 13 18 23 23
Collusion through Joint R&D: An Empirical Assessment 0 0 0 78 2 7 8 193
Collusion through Joint R&D: An Empirical Assessment 0 0 1 64 4 6 8 122
Collusion through joint R&D: An empirical assessment 0 0 0 167 3 6 6 223
Common Ownership Patterns in the European Banking Sector – The Impact of the Financial Crisis 0 0 1 8 2 4 6 15
Common Ownership and Market Entry: Evidence from Pharmaceutical Industry 0 0 0 61 6 9 13 266
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 0 0 60 6 12 19 241
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 0 2 55 3 9 13 98
Common Ownership in the US Pharmaceutical Industry: A Network Analysis 0 0 1 22 4 9 11 73
Common Ownership in the US Pharmaceutical Industry: A Network Analysis 0 0 0 15 0 1 3 42
Common Ownership: Europe vs. the US 0 0 1 6 3 7 10 17
Common ownership and market entry: Evidence from the pharmaceutical industry 0 0 0 98 4 7 12 121
Common ownership and market entry: Evidence from the pharmaceutical industry 0 0 0 17 5 9 13 98
Common ownership in the US pharmaceutical industry: A network analysis 0 0 0 13 7 8 12 42
Common ownership in the US pharmaceutical industry: A network analysis 0 0 0 15 2 6 7 27
Common ownership: Europe vs. the US 0 0 0 5 4 7 11 26
Effective European Antitrust: Does EC Merger Policy Generate Deterrence 0 0 0 44 6 8 9 75
Effective European Antitrust: Does EC Merger Policy Generate Deterrence 0 0 0 34 3 3 4 66
Effective European antitrust: Does EC merger policy generate deterrence? 0 0 0 1 0 2 4 41
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 57 4 5 5 168
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 45 2 9 15 229
Interactions Between Product and Labour Market Reforms 0 0 0 283 6 8 14 1,091
Merger Clusters during Economic Booms 0 0 1 100 2 4 7 395
Merger Failures 0 0 0 450 5 9 13 1,338
Merger failures 0 0 1 229 5 10 17 588
Mergers, Investment Decisions and Internal Organisation 0 0 0 192 3 4 6 476
Mergers, Investment Decisions and Internal Organisation 0 0 0 343 1 5 6 1,291
Mergers, Investment Decisions and Internal Organisation 0 0 0 86 3 6 7 450
Mergers, Investment Decisions and Internal Organisation 0 0 1 6 3 6 8 79
On The Stability of Research Joint Ventures: Implications for Collusion 0 0 0 68 3 4 4 227
On the Stability of Research Joint Ventures: Implications for Collusion 0 0 0 71 3 6 7 270
Ownership Diversification and Product Market Pricing Incentives 0 0 0 1 19 20 23 26
Ownership Diversification and Product Market Pricing Incentives 0 0 0 17 4 14 25 64
Ownership diversification and product market pricing Incentives 0 0 0 2 6 11 19 26
R&D Spillovers through RJV Cooperation 0 0 0 9 3 4 6 26
R&D Spillovers through RJV Cooperation 0 0 0 3 4 7 10 33
R&D Spillovers through RJV Cooperation 0 0 0 5 6 8 11 23
R&D Spillovers throught RJV Cooperation 0 0 0 18 14 19 23 69
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 51 2 4 6 205
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 69 3 6 7 283
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 48 12 13 14 207
Screening and Merger Activity 0 0 0 91 6 8 11 366
The Contingent Effect of Alliance Design on Alliance Dynamics and Performance: An Experimental Study 0 0 0 30 2 5 9 59
The Deterrence Effects of U.S. Merger Policy Instruments 0 0 0 32 3 3 4 144
The Deterrence Effects of U.S. Merger Policy Instruments 0 0 0 15 4 8 12 103
The Dynamics of Research Joint Ventures: A Panel Data Analysis 0 0 0 108 4 4 5 379
The Dynamics of Research Joint Ventures: A Panel Data Analysis 0 0 0 96 2 4 5 317
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 1 1 2 137 9 13 17 145
US and EU Secure Vaccine Production on Home Soil 0 0 0 13 0 0 2 52
USA und EU setzen auf lokale Impfstoffproduktion - Versorgungssicherheit im Fokus 0 0 0 3 1 2 3 27
What Clients Want: Choices between Lawyers' Offerings 0 0 0 13 1 3 7 58
What Clients want: Choices between Lawyers' Offerings 0 0 0 17 1 2 3 51
What clients want: Choices between lawyers' offerings 0 0 0 2 4 8 12 39
Total Working Papers 3 5 58 3,710 272 452 675 11,533
1 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Retrospective Evaluation of the GDF/Suez Merger: Effects on the Belgian Gas Hub 0 0 0 0 1 4 6 8
Ausbau der deutschen Grundbreitbandversorgung: Lehren aus der Vergangenheit mahnen zur Besonnenheit 0 0 0 4 1 3 8 25
Changes in Common Ownership of German Companies 0 2 2 53 5 13 15 189
Collusion Through Joint R&D: An Empirical Assessment 0 0 1 54 3 7 11 206
Common Ownership Patterns in the European Banking Sector—The Impact of the Financial Crisis1 1 2 2 3 3 6 7 10
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 1 2 2 2 8 17 17 17
Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis 0 0 0 0 1 3 3 6
Deutschland muss seine Digitalstrategie überdenken, um den Anschluss nicht zu verlieren: Editorial 0 0 0 3 3 4 9 37
Diversification, Common Ownership, and Strategic Incentives 0 0 0 18 2 3 3 55
EFFECTIVE EUROPEAN ANTITRUST: DOES EC MERGER POLICY GENERATE DETERRENCE? 0 0 0 3 4 6 7 58
EU Competition Policy Enforcement Supports Investment in the Energy Sectors 0 0 0 4 2 6 10 40
EU-Regionalbeihilfen haben positiven Einfluss auf Investitionen 0 0 0 2 1 2 3 15
EU-Wettbewerbspolitik fördert Investitionen in den Energiesektoren 0 0 0 2 1 3 3 33
Effective European Antitrust: Does EC Merger Policy Generate Deterrence? 0 0 0 4 3 4 5 30
Endogenous mergers and endogenous efficiency gains: The efficiency defence revisited 0 0 0 87 5 9 13 283
Europeanization of EU member-state competition policy: The commission's leadership role 0 0 1 14 2 2 4 77
Harte Restriktionen scheinen die wirksamste Maßnahme zu sein, um in einer Pandemie den Flugverkehr zu beschränken: Interview 0 0 0 0 0 0 1 1
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 33 6 7 9 131
Learning dynamics in research alliances: A panel data analysis 0 0 0 32 4 4 9 232
Let’s Not Stick Together: Anticipation of Cartel and Merger Control in The Netherlands 0 0 0 20 3 4 4 91
Mandanten von Anwälten wollen kein Stundenhonorar 0 0 0 1 1 2 2 37
Mehr gemeinsame Anteilseigner, mehr US-Investoren: Eigentümerstrukturen deutscher Firmen haben sich verändert 0 0 0 2 1 2 3 11
Merger Failures 0 0 2 11 8 15 20 189
Nur harte Corona-Regeln wirken sich auf den Passagierflugverkehr zwischen Deutschland und Mallorca aus 0 0 0 1 0 3 3 7
On the Stability of Research Joint Ventures: Implications for Collusion 0 0 0 0 4 5 7 48
Only Strict Coronavirus Regulations for Vacationers Affect Passenger Air Traffic between Germany and Mallorca 0 0 0 0 2 2 4 14
Paying by the Hour: The Least Appealing Option for Clients of Lawyers 0 0 0 0 2 2 3 46
R&D Spillovers through RJV Cooperation 0 0 0 0 12 17 19 20
R&D spillovers through RJV cooperation 0 0 0 4 8 12 16 39
SCREENING AND MERGER ACTIVITY 0 0 0 0 4 7 9 98
SYNCHRONISING DEREGULATION IN PRODUCT AND LABOUR MARKETS 0 0 0 7 3 5 7 51
Schepping en vernietiging van banen: De invloed van O&O-actieve bedrijven 0 0 0 0 1 3 3 31
Settle for Now but Block for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 1 49 5 8 14 198
The Deterrence Effects of US Merger Policy Instruments 0 0 1 19 3 10 14 132
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 0 0 8 11 12 12
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 1 2 4 6 10 12
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 0 3 6 9 13 37
The Pricing Structure of Legal Services: Do Lawyers Offer What Clients Want? 0 0 1 2 3 4 11 21
The political economy of mobile telecommunications liberalization: Evidence from the OECD countries 0 0 0 70 4 9 12 254
Transformational Strategies and Productivity Growth: A Transformational‐Activities Perspective on Stagnation in the New‐Normal Business Landscape 0 0 0 2 3 5 6 18
US-Vermögensverwalter gewinnen in Deutschland an Bedeutung: Interview 0 0 0 0 3 4 7 9
Veränderungen bei gemeinsamen Eigentümerstrukturen deutscher Unternehmen 0 0 0 3 1 2 3 19
Wichtig ist es, die Innovationseffekte der vielen Übernahmen zu berücksichtigen: Interview 0 0 0 0 1 1 2 3
Übernahmen in der Pharmaindustrie: Fokus mehr auf Innovationsmärkte als auf Marktverdrängung richten 0 0 0 1 2 2 3 8
Total Journal Articles 2 6 14 515 147 253 350 2,858
2 registered items for which data could not be found


Statistics updated 2026-02-12